Global Aminoglycosides Market Growth 2023-2029
Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial therapeutic agents that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside (sugar); the term can also refer more generally to any organic molecule that contains aminosugar substructures. Aminoglycoside antibiotics display bactericidal activity against Gram-negative aerobes and some anaerobic bacilli where resistance has not yet arisen but generally not against Gram-positive and anaerobic Gram-negative bacteria.
LPI (LP Information)' newest research report, the “Aminoglycosides Industry Forecast” looks at past sales and reviews total world Aminoglycosides sales in 2022, providing a comprehensive analysis by region and market sector of projected Aminoglycosides sales for 2023 through 2029. With Aminoglycosides sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aminoglycosides industry.
This Insight Report provides a comprehensive analysis of the global Aminoglycosides landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aminoglycosides portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Aminoglycosides market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aminoglycosides and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aminoglycosides.
The global Aminoglycosides market size is projected to grow from US$ 1027.4 million in 2022 to US$ 1161.2 million in 2029; it is expected to grow at a CAGR of 1161.2 from 2023 to 2029.
Asia Pacific accounted for the largest share of revenue in 2014 that is due to higher incidence rate of multi-drug resistant tuberculosis that needs second line drugs for treatment is attributive towards a larger considerably larger share of kanamycin and capreomycin in the Asia Pacific region along with the significant availability of other aminoglycosides as well.
This report presents a comprehensive overview, market shares, and growth opportunities of Aminoglycosides market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Neomycin
Tobramycin
Gentamicin
Amikacin
Paromomycin
Streptomycin
Kanamycin
Others
Segmentation by application
Skin Infection
Respiratory Diseases
UTI & Pelvic Diseases
Other Diseases
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Kremoint Pharma Pvt.
Vega Pharma
Jiangxi Bolai Pharmacy,
Xian Wison Biological Technology,
Hangzhou Uniwise International,
HuvePharma
Yi Chang Veterinary Medicine Factory
Medson Pharmaceuticals
Medico Remedies
Key Questions Addressed in this Report
What is the 10-year outlook for the global Aminoglycosides market?
What factors are driving Aminoglycosides market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aminoglycosides market opportunities vary by end market size?
How does Aminoglycosides break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.